retatrutide ly3437943 phase 2 trial obesity nejm 2023 Results from a new of (LY3437943; Eli Lilly) found that participants had considerable decreases in body weight at week 48, although this depended on the dose and varied due to Retatrutide vs Tirzepatide Compared |
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20














-1781043799568.png&w=3840&q=75)












